Feb. 20 at 11:43 PM
$PGNY What I am looking at going into earnings week:
Growth of covered lives: from Q3 2024 to Q3 2025 covered lives increased ~4.9% from Q3 2023 to Q3 2024 covered lives increased ~18.7%.
Can we get back to robust growth in covered lives or will we see another low to mid-single digit year of growth?
Profit margin increase: FY 2025 has seen consistent margins of > 23%. This is the first time since FY 2021.
Can we see this number stay in the 23’s or grow slightly? or will we return to 19%-22.5% margins we’ve seen the past 3 years?
Drop in Diluted Shares: From Q1 2024 to Q3 2025 diluted shares were reduced approximately 10,000,000 shares (~10%).
Will we continue to see diluted shares drop or will they start to rise again?
Revenue per covered life: Currently, this number depends strongly on utilization rate. The past couple years this number has ranged between
$43.79 -
$49.37.
Can we see this number grow? If the recent partnerships & services offered begin to catch on, we should see an increase.
